New study suggests cancer drug could be used to target protein connection that spurs Parkinson's disease

In studies with genetically engineered mice, researchers say they have identified a potentially new biological target involving Aplp1, a cell surface protein that drives the spread of Parkinson's disease-causing alpha-synuclein.